Abstract:Highlights • We propose a novel drug repurposing approach, which integrates gene expression profile and gene regulatory network to compute inhibition score using the shortest distance in the tissue-specific network, called DRIE. • Experimental results on multiple datasets indicate that DRIE outperforms state-of-the-art methods for cancer drug repurposing prediction. • Case studies show that our method can effectively discover novel drug-disease associations. Numerous computational drug repurposing methods have emerged as efficient alternatives to costly and time-consuming traditional drug discovery approaches. Some of these methods are based on the assumption that the candidate drug should have a reversal effect on disease-associated genes. However, such methods are not applicable in the case that there is limited overlap between disease-related genes and drug-perturbed genes. In this study, we proposed a novel D rug R epurposing method based on the I nhibition E ffect on gene regulatory network ( DRIE ) to identify potential drugs for cancer treatment. DRIE integrated gene expression profile and gene regulatory network to calculate inhibition score by using the shortest path in the disease-specific network. The results on eleven datasets indicated the superior performance of DRIE when compared to other state-of-the-art methods. Case studies showed that our method effectively discovered novel drug-disease associations. Our findings demonstrated that the top-ranked drug candidates had been already validated by CTD database. Additionally, it clearly identified potential agents for three cancers (colorectal, breast, and lung cancer), which was beneficial when annotating drug-disease relationships in the CTD. This study proposed a novel framework for drug repurposing, which would be helpful for drug discovery and development. Availability and implementation The source code of our method is freely available at https://github.com/eshinesimida/DRIE. Graphical abstract Download : Download high-res image (178KB) Download : Download full-size image

When deep learning meets causal inference: a computational framework for drug repurposing from real-world data

A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data

Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network

deepDR: a network-based deep learning approach to in silico drug repositioning

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

A clustering and graph deep learning-based framework for COVID-19 drug repurposing

Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension

Deep learning for drug repurposing: Methods, databases, and applications

DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration

DrugReAlign: a multisource prompt framework for drug repurposing based on large language models

Application of artificial intelligence and machine learning in drug repurposing

High-Throughput Clinical Trial Emulation with Real World Data and Machine Learning: A Case Study of Drug Repurposing for Alzheimer's Disease

DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features

Deep Learning Can Identify Explainable Reasoning Paths of Mechanism of Drug Action for Drug Repurposing from Multilayer Biological Network

Clinical connectivity map for drug repurposing: using laboratory tests to bridge drugs and diseases

A novel efficient drug repurposing framework through drug-disease association data integration using convolutional neural networks

A Drug Repositioning Algorithm Based on a Deep Autoencoder and Adaptive Fusion

A drug repurposing method based on inhibition effect on gene regulatory network

DrugCLIP: Contrastive Drug-Disease Interaction For Drug Repurposing

Machine learning for drug repositioning: Recent advances and challenges

DeepDrug: An Expert-led Domain-specific AI-Driven Drug-Repurposing Mechanism for Selecting the Lead Combination of Drugs for Alzheimer's Disease